W
William E. Kraus
Researcher at Duke University
Publications - 625
Citations - 40583
William E. Kraus is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 93, co-authored 565 publications receiving 33692 citations. Previous affiliations of William E. Kraus include University of Texas Southwestern Medical Center & University of North Carolina at Chapel Hill.
Papers
More filters
and anaerobic threshold A sex-specific relationship between capillary density
E. Kraus,James E. Hansen,Joseph A. Houmard,Brian H. Annex,L. Robbins,Brian D. Duscha,Daniel Bensimhon,Virginia H. Huxley,Jianjie Wang,Judith G. Regensteiner,William R. Hiatt,W. Schuyler Jones,Jason D. Allen,William E. Kraus,M. Sanders,Jennifer L. Robbins,William S Jones,R. John +17 more
Book ChapterDOI
Cardiac Rehabilitation: The Nutrition Counseling Component
William E. Kraus,Julie D. Pruitt +1 more
TL;DR: Recommendations for dietary modification in cardiac rehabilitation include advice to increase the intake of fruits, vegetables, and whole grains, to substitute non-hydrogenated unsaturated fats for saturated and trans-fats, and to increase intake of omega-3 fatty acids.
Journal ArticleDOI
Effects of Lifestyle Modification on Psychosocial Function in Patients With Resistant Hypertension: SECONDARY OUTCOMES FROM THE TRIUMPH RANDOMIZED CLINICAL TRIAL.
James A. Blumenthal,Patrick Smith,Stephanie Mabe,Alan L. Hinderliter,Linda W. Craighead,Lana L. Watkins,Krista K. Ingle,Crystal C. Tyson,Pao-Hwa Lin,William E. Kraus,Andrew Sherwood +10 more
TL;DR: In a secondary analysis of the TRIUMPH clinical trial, psychological outcomes in patients with resistant hypertension were compared with those receiving a similar prescription of diet and exercise provided in a single counseling session by a health educator as discussed by the authors .
Journal ArticleDOI
Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery
Jörn Karhausen,Wenjing Qi,Alan M. Smeltz,Yi-Ju Li,Svati H. Shah,William E. Kraus,Joseph P. Mathew,Mihai V. Podgoreanu,Miklos D. Kertai,Miklos D. Kertai +9 more
TL;DR: Because SPRY2-an endogenous receptor tyrosine kinase inhibitor-is present in platelets and modulates essential signalling pathways, these findings support a role for SPRy2 as a novel modulator of platelet responses after cardiac surgery.
Journal ArticleDOI
Early Identification of Patients at Risk for Incident Heart Failure With Preserved Ejection Fraction: Novel Approach to Echocardiographic Trends.
Carolyn L. Lekavich,Dennis M. Abraham,Marat Fudim,Marat Fudim,Cynthia L. Green,Robert J. Mentz,Robert J. Mentz,Karol Harshaw-Ellis,Margaret Bowers,Anita M. Kelsey,Kishan S. Parikh,Kishan S. Parikh,Tracy Truong,Debra J. Barksdale,William E. Kraus,William E. Kraus +15 more
TL;DR: In this article, changes in echocardiographic markers preceding acute heart failure decompensation owing to incident heart failure with preserved ejection fraction (HFpEF) were analyzed using linear mixed effects models.